| Type | MGI:General | Description | CD40 treatment of B cells induces fewer mutant cells to progress to S and G2/M phases than wild-type cells, while number of mutant cells entering cell cycle after IgM or LPS treatment is dramatically decreased compared to treated wild-type cells |
